140 related articles for article (PubMed ID: 11514148)
1. Biflavonoids as novel antituberculosis agents.
Lin YM; Flavin MT; Cassidy CS; Mar A; Chen FC
Bioorg Med Chem Lett; 2001 Aug; 11(16):2101-4. PubMed ID: 11514148
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
3. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
[TBL] [Abstract][Full Text] [Related]
5. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S
Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones.
Koçyiğit KB; Rollas S
Farmaco; 2002 Jul; 57(7):595-9. PubMed ID: 12164221
[TBL] [Abstract][Full Text] [Related]
8. Chalcones and flavonoids as anti-tuberculosis agents.
Lin YM; Zhou Y; Flavin MT; Zhou LM; Nie W; Chen FC
Bioorg Med Chem; 2002 Aug; 10(8):2795-802. PubMed ID: 12057669
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents.
Yoya GK; Bedos-Belval F; Constant P; Duran H; Daffé M; Baltas M
Bioorg Med Chem Lett; 2009 Jan; 19(2):341-3. PubMed ID: 19084396
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitubercular activity of 4-(3-coumarinyl)-3-cyclohexyl-4-thiazolin-2-one benzylidenehydrazones.
Karali N; Kocabalkanli A; Gürsoy A; Ateş O
Farmaco; 2002 Jul; 57(7):589-93. PubMed ID: 12164220
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
Karakuş S; Rollas S
Farmaco; 2002 Jul; 57(7):577-81. PubMed ID: 12164218
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
[TBL] [Abstract][Full Text] [Related]
14. Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents.
Tawari NR; Bag S; Raju A; Lele AC; Bairwa R; Ray MK; Rajan MG; Nawale LU; Sarkar D; Degani MS
Future Med Chem; 2015; 7(8):979-88. PubMed ID: 26062396
[TBL] [Abstract][Full Text] [Related]
15. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of alpha- and beta-pyran naphthoquinones as a new class of antitubercular agents.
Ferreira SB; de Carvalho da Silva F; Bezerra FA; Lourenço MC; Kaiser CR; Pinto AC; Ferreira VF
Arch Pharm (Weinheim); 2010 Feb; 343(2):81-90. PubMed ID: 20077521
[TBL] [Abstract][Full Text] [Related]
18. A new class of antituberculosis agents.
Jones PB; Parrish NM; Houston TA; Stapon A; Bansal NP; Dick JD; Townsend CA
J Med Chem; 2000 Aug; 43(17):3304-14. PubMed ID: 10966749
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antituberculosis activity of the first macrocyclic glycoterpenoids comprising glucosamine and diterpenoid isosteviol.
Garifullin BF; Strobykina IY; Sharipova RR; Kravchenko MA; Andreeva OV; Bazanova OB; Kataev VE
Carbohydr Res; 2016 Aug; 431():15-24. PubMed ID: 27267064
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.
Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB
Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
